{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:27:11Z","timestamp":1792740431712,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":786,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.fertnstert.2019.12.006","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:45:41Z","timestamp":1583455541000},"page":"788-796.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve"],"prefix":"10.1016","volume":"113","author":[{"given":"Ashley W.","family":"Tiegs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Richard T.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea R.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2019.12.006_bib1","first-page":"571","article-title":"M\u00fcllerian inhibiting substance in humans: normal levels from infancy to adulthood","volume":"81","author":"Lee","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib2","first-page":"3836","article-title":"Expression of anti-M\u00fcllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells","volume":"84","author":"Rajpert-De Meyts","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/rep.0.1240601","article-title":"Regulation of ovarian function: the role of anti-M\u00fcllerian hormone","volume":"124","author":"Durlinger","year":"2002","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib4","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2008-0567","article-title":"Anti-M\u00fcllerian hormone and inhibin B in the definition of ovarian aging and the menopause transition","volume":"93","author":"Sowers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.GME.0000123642.76105.6E","article-title":"Anti-M\u00fcllerian hormone is a promising predictor for the occurrence of the menopausal transition","volume":"11","author":"van Rooij","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","article-title":"Serum antiM\u00fcllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study","volume":"83","author":"van Rooij","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"AntiM\u00fcllerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/humrep\/deh688","article-title":"High reproducibility of serum anti-M\u00fcllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status","volume":"20","author":"Fanchin","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib9","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/dem101","article-title":"Stable serum levels of anti-M\u00fcllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women","volume":"22","author":"Tsepelidis","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib10","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-M\u00fcllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib11","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1471-0528.2004.00452.x","article-title":"Inhibin B and anti-M\u00fcllerian hormone: markers of ovarian response in IVF\/ICSI patients?","volume":"111","author":"Muttukrishna","year":"2004","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib12","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1471-0528.2005.00670.x","article-title":"Antral follicle count, anti-M\u00fcllerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?","volume":"112","author":"Muttukrishna","year":"2005","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib13","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-M\u00fcllerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humrep\/dei270","article-title":"M\u00fcllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology","volume":"21","author":"Silberstein","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib15","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/del127","article-title":"Basal level of anti-M\u00fcllerian hormone is associated with oocyte quality in stimulated cycles","volume":"21","author":"Ebner","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","article-title":"Early follicular antiM\u00fcllerian hormone as an indicator of ovarian reserve","volume":"85","author":"Ficicioglu","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib17","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/humrep\/den108","article-title":"Relevance of anti-M\u00fcllerian hormone measurement in a routine IVF program","volume":"23","author":"Gnoth","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","article-title":"Basal and stimulation day 5 anti-M\u00fcllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin releasing hormone agonist\u2013gonadotropin treatment","volume":"20","author":"Penarrubia","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.rbmo.2010.02.007","article-title":"Prospective investigation of serum anti-M\u00fcllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study","volume":"20","author":"Freiesleben","year":"2010","journal-title":"Repro Biomed Online"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib20","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.fertnstert.2009.12.059","article-title":"Evaluating the performance of serum anti-M\u00fcllerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination","volume":"94","author":"Li","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3109\/01443615.2013.810199","article-title":"Factors influencing the outcome of intrauterine insemination (IUI): age, clinical variables and significant thresholds","volume":"33","author":"Speyer","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/01443615.2014.935718","article-title":"A higher anti-M\u00fcllerian hormone level is associated with an increased chance of pregnancy in patients undergoing controlled ovarian stimulation and intrauterine insemination","volume":"35","author":"Wang","year":"2015","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/09513590.2015.1025381","article-title":"Can anti-M\u00fcllerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation?","volume":"31","author":"Bakas","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jogc.2017.01.029","article-title":"The value of anti-m\u00fcllerian hormone in predicting clinical pregnancy after intrauterine insemination","volume":"39","author":"Dondik","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/09513590.2018.1499089","article-title":"Can anti-M\u00fcllerian hormone predict success outcomes in donor sperm inseminations?","volume":"35","author":"Gonzalez-Foruria","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/JCMA.0000000000000023","article-title":"The role of anti-M\u00fcllerian hormone in prediction of pregnancy in young and older women with unexplained infertility undergoing intrauterine insemination","volume":"82","author":"Seckin","year":"2019","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.fertnstert.2004.10.030","article-title":"Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles","volume":"83","author":"Dickey","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib28","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/humrep\/dey238","article-title":"Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance","volume":"33","author":"Morin","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.12.006_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.fertnstert.2009.03.032","article-title":"Assay reproducibility and within-person variation of M\u00fcllerian inhibiting substance","volume":"94","author":"Dorgan","year":"2010","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502821932607X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502821932607X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:25:46Z","timestamp":1758011146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502821932607X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S001502821932607X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2019.12.006","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2019.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92019 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}